Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Revenue

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹7,896 Cr₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr

What is the latest Revenue of EMCURE PHARMACEUTICALS ?

The latest Revenue ratio of EMCURE PHARMACEUTICALS is ₹7,896 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹7,896 Cr
Mar2024₹6,658 Cr
Mar2023₹5,986 Cr
Mar2022₹5,855 Cr
Mar2021₹6,056 Cr

How is Revenue of EMCURE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹7,896 Cr
18.59
Mar2024 ₹6,658 Cr
11.23
Mar2023 ₹5,986 Cr
2.23
Mar2022 ₹5,855 Cr
-3.32
Mar2021 ₹6,056 Cr -

Compare Revenue of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹30,350.2 Cr 3.1% 5.3% 55% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

3.1%

5.3%

55%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses